T1	Participants 40 75	children and young adults with HIV:
T2	Participants 172 193	HIV-infected patients
T3	Participants 452 474	HIV-infected subjects.
T4	Participants 516 637	perinatally acquired HIV (PHIV)-infected subjects or behaviorally acquired HIV (BHIV)-infected subjects (5.0-24.9 years).
T5	Participants 746 863	Fifty-eight subjects enrolled (67% male, 85% African American and 64% BHIV) and 50 completed with no safety concerns.
